ZeptoMetrix™ Releases New Respiratory Verification Panel for Molecular Quality Control
New 20-Member Respiratory Verification Panel (# NATRVP-QIA) for use in laboratories engaged in utilizing molecular diagnostics technologies when testing for infectious diseases.
BUFFALO, N.Y., July 2, 2019 /PRNewswire-PRWeb/ -- ZeptoMetrix™ Corporation (ZMC) has released a new 20-member respiratory verification panel for use in laboratories engaged in utilizing molecular diagnostics technologies when testing for infectious diseases.
"Our focus is to provide both strategic collaborators and end-use customers with reliable, easy-to-use, and cost-effective external QC controls for their various laboratory needs", explains Shawn R. Smith, President and CEO of ZeptoMetrix. "As industry leaders such as QIAGEN® gain approval to market novel approaches to testing for infectious diseases, such as the QIAstat-Dx® syndromic testing system, we seek to develop versatile tools that assist in the effort to ensure optimal performance within the testing labs. The recent release of our NATtrol™ Respiratory Verification Panel (# NATRVP-QIA) provides such laboratories with another example of how ZeptoMetrix is focused on supporting the diagnostic testing community with an ever-expanding portfolio of industry-leading products."
About ZeptoMetrix™
ZeptoMetrix Corporation (ZMC) is an established industry leader in the design, development, and delivery of innovative, quality solutions to the Infectious Disease Diagnostics Market. Our expertise and abilities in Molecular Diagnostics, including External Quality Controls, Verification Panels, Proficiency Panels, Customized and OEM Products/Services have set the industry standard for performance and reliability and made ZeptoMetrix the preferred choice for independent 3rd party QC materials.
Founded in 1999, ZeptoMetrix is headquartered in Buffalo, NY with additional facilities in Franklin, Massachusetts.
About NATtrol™
Globally, millions of people are tested for infectious diseases each year. The implications of reporting either a false positive or a false negative can be devastating to the patient. Accurate and sensitive diagnostics are necessary to confirm that laboratories are providing patients with proper testing results. Utilizing ZeptoMetrix NATtrol QC materials on a consistent basis helps to monitor testing performance and enhance confidence in testing results.
ZeptoMetrix NATtrol Molecular Diagnostics products are an essential component of today's ever-evolving testing market and are designed to provide safe, accurate and cost-effective support for activities relating to the analysis and identification of possible disease-causing microorganisms. The patented ZeptoMetrix NATtrol process renders highly-purified microorganisms non-infectious while allowing internal nucleic acids to remain intact, thereby serving as an ideal reference material for molecular diagnostic testing applications. Representing a total process control, from DNA extraction through amplification and eventual detection, NATtrol products are ready-to-use, refrigerator stable, and safe for operators to handle.
The routine and repetitive use of NATtrol™ External Run Controls and Verification Panels help enable laboratories to monitor performance and identify trends in daily test variations, test kit lot changes, and among individual operators.
For Sales and/or information regarding ZeptoMetrix, NATtrol Molecular Quality Controls & Panels, and Development/Custom Services, please contact ZeptoMetrix Customer Service.
Contact:
ZeptoMetrix Corporation, Customer Service
878 Main Street
Buffalo, NY 14202
716-882-0920
custserv(at)zeptometrix(dot)com
http://www.zeptometrix.com
Media:
Michael Hershfield, Vice President, Sales & Marketing
508-553-5852
mhershfield(at)zeptometrix(dot)com
SOURCE ZeptoMetrix Corporation
Share this article